Effects of Temperature and Time on the Denaturation of Transforming Growth Factor Beta-1 and Cytokines from Bovine Platelet-Rich Gel Supernatants DOI Creative Commons
Jorge U. Carmona, Catalina López

Gels, Journal Year: 2024, Volume and Issue: 10(9), P. 583 - 583

Published: Sept. 11, 2024

There is a lack of information about transforming growth factor beta-1 (TGF-β

Language: Английский

Aging: a Struggle for Beneficial to Overcome Negative Factors made by Muscle and Bone DOI
Steven S. Welc,

Marco Brotto,

Kenneth E. White

et al.

Mechanisms of Ageing and Development, Journal Year: 2025, Volume and Issue: unknown, P. 112039 - 112039

Published: Feb. 1, 2025

Language: Английский

Citations

0

TGF-β: elusive target in diabetic kidney disease DOI Creative Commons
Priya Rani, Sindhura Lakshmi Koulmane Laxminarayana, Shilna Muttickal Swaminathan

et al.

Renal Failure, Journal Year: 2025, Volume and Issue: 47(1)

Published: April 3, 2025

Transforming growth factor-beta (TGF-β), a cytokine with near omnipresence, is an integral part of many vital cellular processes across the human body. The family includes three isoforms: 1, 2, and 3. These cytokines play significant role in fibrosis cascade. Diabetic kidney disease (DKD), major complication diabetes, increasing prevalence daily, classical diagnosis diabetes based on presence albuminuria. occurrence nonalbuminuric DKD has provided new insight into pathogenesis this disease. emphasis multifactorial pathways involved developing highlighted some markers associated tissue fibrosis. In diabetic nephropathy, TGF-β significantly its pathology. Its serum urine means that it could be diagnostic tool while regulation provides potential therapeutic targets. Completely blocking signaling reach untargeted regions cause unanticipated effects. This paper reviews basic details as cytokine, DKD, updates research carried out to validate candidacy.

Language: Английский

Citations

0

Recent Stem-Cell-Based and Stem-Cell-Free Possibilities for the Therapeutic Management of the Osteonecrosis of the Jaw DOI Creative Commons

Merita Mazreku,

Ľuboš Danišovič, Martin Klein

et al.

Biomolecules, Journal Year: 2025, Volume and Issue: 15(4), P. 595 - 595

Published: April 16, 2025

Osteonecrosis of the jaw (ONJ), including maxilla and mandible, is considered a challenging therapeutic problem, mainly due to lack understanding its pathogenesis. It well known that ONJ severe side effect caused by certain medications used treat bone metastasis osteoporosis, such as bisphosphonates, which inhibit resorption. Other therapeutics with similar effects are, for instance, receptor activators nuclear factor kappa-B ligand (RANK-L) inhibitor (denosumab), tyrosine kinase inhibitors (sunitinib), antiangiogenics (bevacizumab). The conservative or surgical treatment these medication-related osteonecroses (MRONJs) generally effortful still not entirely effective. Therefore, research seeks alternative options like tissue engineering stem cell therapy, predominantly represent mesenchymal cells (MSCs) their derivatives, extracellular vesicles. Moreover, it was published novel therapy could even prevent onset MRONJ. On other hand, administration may also be accompanied some health risks, an increased chance cancer occurrence in patients. current review paper summarizes most recent progress stem-cell-based stem-cell-free ONJ. Similarly, we discuss this approach’s future perspectives possible obstacles.

Language: Английский

Citations

0

Effects of Temperature and Time on the Denaturation of Transforming Growth Factor Beta-1 and Cytokines from Bovine Platelet-Rich Gel Supernatants DOI Creative Commons
Jorge U. Carmona, Catalina López

Gels, Journal Year: 2024, Volume and Issue: 10(9), P. 583 - 583

Published: Sept. 11, 2024

There is a lack of information about transforming growth factor beta-1 (TGF-β

Language: Английский

Citations

0